SCHB vs XBI

Schwab US Broad Market ETF vs SPDR S&P Biotech ETF

Quick take
  • • SCHB has the lower expense ratio at 0.03% vs 0.35% for XBI.
  • • SCHB pays a higher dividend yield (1.06%).

Side-by-side metrics

MetricSCHBXBI
Expense ratio
Annual fee. Lower is better.
0.03%0.35%
Dividend yield
Trailing 12-month yield.
1.06%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$44.23B$10.92B
YTD return
11.46%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.001.01
P/E ratio
23.16—
Last price
$29.32$156.41
Inception
——
Issuer
SchwabState Street

SCHB top holdings

Top holdings · SCHB
AAPLApple Inc6.87%
NVDANVIDIA Corp6.76%
MSFTMicrosoft Corp5.29%
AMZNAmazon.com Inc3.22%
GOOGLAlphabet Inc Class A2.24%
AVGOBroadcom Inc2.12%
METAMeta Platforms Inc Class A1.85%
GOOGAlphabet Inc Class C1.81%
LLYEli Lilly and Co1.55%
TSLATesla Inc1.54%
Sector breakdown · SCHB
Real Estate2.2%
Consumer Cyclical9.2%
Basic Materials1.8%
Consumer Defensive4.7%
Technology36.3%
Communication Services7.8%
Financial Services12.3%
Utilities2.1%
Industrials8.8%
Energy4.1%
Healthcare10.8%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About SCHB

SCHB (Schwab US Broad Market ETF) is Total US equity market. Managed by Schwab, the fund carries $44.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.06%. Its largest holding is Apple Inc (AAPL), which represents 6.9% of the portfolio. Real Estate is the fund's largest sector exposure at 2.2%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.